Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 13, 2019

Importance of Differentiating Lung and Liver Metastases in Breast Cancer Patients Prior to Treatment With Fulvestrant

Cancer Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancer Medicine
Metastatic Breast Cancer Patients With Lung or Liver Metastases Should Be Distinguished Before Being Treated With Fulvestrant
Cancer Med 2019 Aug 02;[EPub Ahead of Print], M He, J‐J Li, W‐J Zuo, L Ji, Y‐Z Jiang, X‐C Hu, Z‐H Wang, Z‐M Shao

Further Reading